Atypical Presentation of Acute Angle-Closure Glaucoma in Maroteaux-Lamy Mucopolysaccharidosis with Patent Prophylactic Laser Peripheral Iridotomy: A Case Report

Perm J. 2017:21:17-012. doi: 10.7812/TPP/17-012.

Abstract

Introduction: Maroteaux-Lamy syndrome (MLS) is a rare progressive condition characterized by inflammation and scarring of multiple organs. Ocular complications caused by anterior segment abnormalities commonly cause visual impairment in MLS. Angle-closure glaucoma is one such complication, but there are limited data on presentation, workup, and management of this condition.

Case presentation: This case report describes an atypical presentation of acute angle-closure glaucoma in a patient with MLS despite a prior prophylactic laser peripheral iridotomy-which would typically prevent an acute angle-closure attack-that was patent and intact at the time of angle closure.

Discussion: Because of severe congenital anterior segment crowding, high axial hyperopia, and constant accommodative demand in patients with MLS, we recommend performing two prophylactic laser peripheral iridotomies simultaneously in the same eye instead of one. The mechanism for this indication differs from that in patients at risk of acute angle-closure glaucoma because of lens zonulopathy alone. We hope that this case report may help prevent vision loss and optimize quality of life in patients with MLS who may be wheelchair-bound but are typically high functioning with normal intelligence.

Publication types

  • Case Reports

MeSH terms

  • Acetazolamide / therapeutic use*
  • Adult
  • Carbonic Anhydrase Inhibitors / therapeutic use*
  • Female
  • Glaucoma, Angle-Closure / drug therapy*
  • Glaucoma, Angle-Closure / etiology
  • Glaucoma, Angle-Closure / physiopathology
  • Glaucoma, Angle-Closure / surgery*
  • Humans
  • Iridectomy / methods
  • Laser Therapy / methods
  • Mucopolysaccharidosis VI / complications*
  • Mucopolysaccharidosis VI / physiopathology
  • Mucopolysaccharidosis VI / surgery*
  • Treatment Outcome

Substances

  • Carbonic Anhydrase Inhibitors
  • Acetazolamide